Biospecimen Core
Biospecimen Core
批准号:
10628276
负责人:
Mark M. Pomerantz
金额:
$21.91万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-01 至 2028-08-31
关键词:
AccelerationAnimal ModelAntibodiesAwardBar CodesBiocompatible MaterialsBiological AssayBiological Specimen BanksBiometryBiopsyBloodCancer CenterCancer PatientCellularityClinicalClinical DataCollectionComputational BiologyComputer-Assisted Image AnalysisConfidentiality of Patient InformationConsentDNADana-Farber Cancer InstituteDataData AnalysesData CollectionData Management ResourcesDatabasesDevelopmentEnsureEquipment and supply inventoriesEvaluationFormalinFreezingFutureGeneral HospitalsGoalsHospitalsHumanImaging technologyImmunofluorescence ImmunologicImmunohistochemistryInfrastructureInstitutionIsraelLinkMalignant neoplasm of prostateMassachusettsMedical centerMolecularMolecular AnalysisOutcomeParaffin EmbeddingPathologicPathologyPatientsPerformancePre-Clinical ModelProceduresProcessProstateProstatectomyProstatic NeoplasmsProteinsProtocols documentationPublic Health SchoolsQuality ControlRNAResearch PersonnelResearch Project GrantsResourcesSamplingSecureServicesShippingSlideSpecimenStainsStandardizationSystemTechnologyTissue MicroarrayTissue ModelTissuesTranslational ResearchValidationWomanWorkbiobankcancer Biomedical Informatics Gridcareerclinical databaseexperimental studyhuman modelhuman tissuelaser capture microdissectionmouse modelneoplasticnovelprogramssample collectionsuccesstissue fixingtooltumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY – BIOSPECIMEN CORE (CORE C)
Acquisition and characterization of biospecimens linked with clinical data and the development of
patient relevant preclinical models, are essential components for effective and impactful translational
research. The Dana Farber/ Harvard Cancer Center (DF/HCC) Prostate SPORE Biospecimen Core (Core
C) will maintain and expand a mature prostate cancer biorepository, including blood and tissue specimens,
from a diverse group of prostate cancer patients across DF/HCC who have provided consent to our clinical
database and biobank protocols. Core C will provide tissue specimens and vast pathology expertise to
SPORE investigators including the evaluation of both human and mouse model tissues. Core C will
maintain a database of clinical data on all consented patients, linked with standardized pathology review
procedures and data collection. Core C will work closely with SPORE investigators and collaborators to
provide interpretative and consultative pathology services, including stateoftheart molecular assays
and imaging technologies developed at DF/HCC. Centralization of Core activities builds upon
established infrastructure but does not replicate existing resources within the DF/HCC. Overall, Core C
will greatly facilitate and accelerate translational research within the DF/HCC Prostate SPORE through
the collection and integration of highly annotated biological material and associated clinical information.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金